HP03A NOVEL AND SAFE DEVICE FOR HEPATIC PARENCHYMAL TRANSECTION DURING LIVER RESECTION: THE GYRUS PLASMAKINETIC PULSED BIPOLAR COAGULATION FORCEPS

• Published in: ANZ journal of surgery Vol. 77; no. s1; p. A40
• Main Authors: Tan, J. T. H., Hunt, A. S., Delriviere, L., Mitchell, A. W. S.
• Format: Journal Article
• Language: English
• Published: Melbourne, Australia Blackwell Publishing Asia 01.05.2007; Blackwell Publishing Ltd
• Subjects: Abdominal surgery; Coagulation; Liver; Medical equipment; Surgical techniques
• ISSN: 1445-1433; 1445-2197
• DOI: 10.1111/j.1445-2197.2007.04122_3.x

The Gyrus PlasmaKinetic bipolar coagulation device has been described for use in most types of abdominal surgery. However, its use in liver resection has, to date, not been described. This study has been conducted to evaluate the safety and efficacy of the Gyrus PlasmaKinetic bipolar coagulation device during the parenchymal transection phase of both open and laparoscopic liver resections. A retrospective review was undertaken of 30 consecutive liver resections using the Gyrus Plasmakinetic pulsed bipolar coagulation device. The study period was from July 20, 2005 to November 1, 2006. Post-operative morbidity, mortality, and need for blood transfusion were measured. There were 18 males and 12 females. The average age was 54.8 +/- 13.8 yrs, with a range of 29 to 87 yrs. There were 27 open procedures and 3 laparoscopic procedures. Of these, there were 13 major resections (greater or equal to 3 segments) and 17 minor resections (<3 segments). Six patients had histopathological confirmation of cirrhosis in the adjacent liver. Average operation time was 263.1 +/-117.2 min. Length of stay had a median of 9 days. 16 patients (53.3%) did not require any blood transfusion. There was no difference in the proportion of patients receiving a blood transfusion between the cirrhotic and non-cirrhotic groups (p = 0.46). There were no post-operative deaths. 6 patients (20 %) had significant post-operative complications. The Gyrus PlasmaKinetic system is safe and efficacious for use in hepatic parenchymal transection when used together with Argon beam coagulation and other more traditional haemostatic strategies in both cirrhotic and non-cirrhotic livers. [PUBLICATION ABSTRACT]